Answers are grounded in this paper and cite their sources.
clinical perspective, we suggest that NLE should be considered possible in an infant when there is a history of autoimmune connective tissue disease or appropriate circulating IgG autoantibodies in the gestational mother.
No takes yet. Share an insight, caveat, or question.
Chiou et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: